1
|
Argyropoulos CD, Leckler J, Salmanton-García J, Constantinou M, Alexandrou A, Themistocleous S, Noula E, Shiamakkides G, Nearchou A, Stewart FA, Albus K, Koniordou M, Kopsidas I, Spivak O, Hellemans M, Hendrickx G, Davis RJ, Azzini AM, Simon PV, Carcas AJ, Askling HH, Vene S, Prellezo JB, Álvarez-Barco E, Macken AJ, Di Marzo R, Luís C, Olesen OF, Frias Iniesta JA, Barta I, Tóth K, Akova M, Bonten MMJ, Cohen-Kandli M, Cox RJ, Součková L, Husa P, Jancoriene L, Launay O, Lundgren J, Mallon P, Mendonça MA, Marques L, Naucler P, Ochando J, Tacconelli E, van Damme P, Zaoutis T, Hofstraat S, Bruijning-Verhagen P, Zeitlinger M, Cornely OA, Pana ZD. Enhancing public health communication of vaccine trials: The pan-European VACCELERATE Toolkit. JMIR Public Health Surveill 2023; 9:e44491. [PMID: 36878478 PMCID: PMC10131613 DOI: 10.2196/44491] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 02/09/2023] [Accepted: 02/28/2023] [Indexed: 03/08/2023] Open
Abstract
BACKGROUND The pan-European VACCELERATE network aims to implement the first transnational harmonised and sustainable vaccine trial Volunteer Registry, serving as single entry-point for volunteers willing to participate in large scale vaccine clinical studies across the European region. The present work exhibits a set of harmonised vaccine trial educational and promotional tools for the general public, designed and disseminated by the pan-European VACCELERATE network. OBJECTIVE The main objectives of the present study are the design and creation of a standard toolkit to increase positive attitudes, and access to trustful information for better access and increased recruitment to vaccine trials for the public community. More specifically, the produced tools are focused on inclusiveness, equity, and they are targeting different population groups, including underserved ones, as potential volunteers for the VACCELERATE Volunteer Registry (elderly, migrants, children and adolescents). The promotion/education material is aligned with the main objectives of the Volunteer Registry, to increase public literacy and awareness regarding vaccine clinical research/trials and trial participation, such as informed consent and legal issues, side effects and frequently asked questions on vaccine trial design. METHODS The tools' development has followed the aims and principles of the VACCELERATE project, focusing on trial inclusiveness and equity and they are adjusted to the local country requirements to improve public health communication. The selection of the produced tools has been based on the cognitive theory, inclusiveness and equity of different aged and under-represented groups, and standardised material from several official trustful sources (e.g. COVAX, ECDC, EUPATI, GAVI and WHO). In addition, team of specialists from different fields (infectious diseases, vaccine research, medicine, education) edited and reviewed the subtitles and scripts for the educational videos, extended brochures, interactive cards and puzzles. Graph designers also selected the colour palette, audio settings and dubbing for the video story-tales and implementation of QR codes. RESULTS This study presents the first set of harmonised promotional and educational materials/tools (i.e. educational cards, educational and promotional videos, extended brochures, flyers, posters, and puzzles) for vaccine clinical research (e.g. COVID-19). The developed tools inform the public about possible benefits and disadvantages of trial participation, but also build the confidence of participants about the safety and efficacy for COVID-19 vaccines and healthcare system. The present material has been translated into several languages and meant to be freely and easily accessible to facilitate dissemination among the participating countries of the VACCELERATE network, as well as among the European and global scientific, industrial, and public community, in general. CONCLUSIONS The produced material could also be useful for filling knowledge gaps of healthcare personnel and providing the appropriate future patient education for vaccine trials, as well as to tackle vaccine hesitancy and parents' concerns for potential participation of children in vaccine trials.
Collapse
Affiliation(s)
| | - Janina Leckler
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | - Jon Salmanton-García
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | | | | | | | - Evgenia Noula
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| | - George Shiamakkides
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| | - Andria Nearchou
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| | - Fiona A Stewart
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | - Kerstin Albus
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | - Markela Koniordou
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, GR
| | - Ioannis Kopsidas
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, GR
| | | | - Margot Hellemans
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, BE
| | - Greet Hendrickx
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, BE
| | - Ruth Joanna Davis
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, IT
| | - Anna Maria Azzini
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, IT
| | - Paula Valle Simon
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, ES.,Servicio Madrileño de Salud, Madrid, ES
| | - Antonio Javier Carcas
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, ES.,Servicio Madrileño de Salud, Madrid, ES
| | - Helena Hervius Askling
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SE.,Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SE
| | - Sirkka Vene
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SE.,Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SE
| | | | - Elena Álvarez-Barco
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, IE
| | - Alan J Macken
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, IE
| | | | | | - Ole F Olesen
- European Vaccine Initiative (EVI), Heidelberg, DE
| | - Jesus A Frias Iniesta
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, ES.,Servicio Madrileño de Salud, Madrid, ES
| | - Imre Barta
- National Koranyi Institute for Pulmonology, Budapest, HU
| | - Krisztina Tóth
- National Koranyi Institute for Pulmonology, Budapest, HU
| | | | - Marc M J Bonten
- Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, NL.,Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, NL
| | | | | | - Lenka Součková
- Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, CZ.,University Hospital Brno, Brno, CZ.,CZECRIN, Brno, CZ
| | - Petr Husa
- Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, CZ.,University Hospital Brno, Brno, CZ.,CZECRIN, Brno, CZ
| | - Ligita Jancoriene
- Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, LT.,Vilnius University Hospital Santaros klinikos, Medical Faculty, Vilnius University, Vilnius, LT
| | - Odile Launay
- Institut National de la Santé et de la Recherche Médicale-ANRS Maladies Infectieuses Émergentes, Paris, FR.,Université Paris Cité, Assistance Publique Hopitaux de Paris, Paris, FR
| | - Jens Lundgren
- Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, DK
| | - Patrick Mallon
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, IE
| | | | | | - Pontus Naucler
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SE.,Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SE
| | - Jordi Ochando
- Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, ES
| | - Evelina Tacconelli
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, IT
| | - Pierre van Damme
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, BE
| | - Theoklis Zaoutis
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, GR
| | - Sanne Hofstraat
- University Medical Centre Utrecht, Utrecht University, Utrecht, NL
| | | | | | - Oliver A Cornely
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, DE.,German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, DE
| | - Zoi Dorothea Pana
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| |
Collapse
|